decisionhealth Newsletters, Part B News - 2011 Issue 12 (December)
Medicare prohibits drug ‘brown bagging’ in 2012
Subscribe or sign in to view the full article.
Article Overview
This article is for physician practices, billing staff, and coders who work with injectable drug administration and Medicare Part B billing. It summarizes a 2012 Medicare policy update, contrasts it with private payer specialty pharmacy arrangements, and points readers to related CMS and payer guidance. The focus is on operational billing policy, not on clinical treatment decisions.
Why This Topic Matters
Practices that handle high-cost injectable drugs need to understand how Medicare’s billing rules changed and how that affects office workflows, claims submission, and relationships with pharmacies and payers.
What You Will Learn
- How a Medicare policy update affected billing for drugs administered in a physician office
- How the article contrasts Medicare billing practices with private payer specialty pharmacy arrangements
- Which CMS and payer resources the article references for additional context
- Why the change matters for practices that administer high-cost injectable drugs
Who Should Read This
- Physician practices
- Medical billing staff
- Coders
- Practice managers
- Orthopedic practices
- Specialty pharmacy stakeholders
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com